NCT01300689
Unknown
Not Applicable
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HPV Infection
- Sponsor
- Chinese Academy of Medical Sciences
- Enrollment
- 3000
- Locations
- 1
- Last Updated
- 15 years ago
Overview
Brief Summary
This is a observational study aims to assess anal and genital human papillomavirus (HPV) infection status among men who have sex with men (MSM) in China, and their knowledge and attitude about HPV vaccine.
Investigators
Eligibility Criteria
Inclusion Criteria
- •≥ 18 years old;
- •Ever had homosexual behaviors in the past 12 months;
- •Willing to take tests for HIV/HPV infection;
- •Physically able and willing to provide written informed consent.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Not Applicable
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenHIV InfectionHuman Papillomavirus InfectionHuman Papillomavirus-Related CarcinomaNCT04142398AIDS Malignancy Consortium246
Completed
Not Applicable
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi ArabiaInfections, PapillomavirusCervical CancerNCT01213459GlaxoSmithKline420
Completed
Not Applicable
Anal Human Papillomavirus in Inflammatory Bowel Disease StudyInflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)Crohn's Disease (CD)Anal Human PapillomavirusNCT01364896University of Pittsburgh46
Recruiting
Not Applicable
Prevalence and Clinical Implications of HPV Infection in Male IBD PatientsHPV InfectionDysplasia AnusOral Cavity DiseaseNCT05911750Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau384
Completed
Not Applicable
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in EgyptHuman Papillomavirus InfectionNCT01158209GlaxoSmithKline490